2015
DOI: 10.1016/j.bbrc.2015.03.154
|View full text |Cite
|
Sign up to set email alerts
|

Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 32 publications
0
16
0
Order By: Relevance
“…Ghrelin also improves the histopathological changes in the liver (44). Wild ginseng cambial meristematic cells protect the liver against GalN-induced inflammation, and sesamin ameliorates D-GaIN/lipopolysaccharide-induced hepatic damage (45,46). Forsythiaside has also been reported as a protective compound against lipopolysaccharide (LPS)/D-GalN-induced liver injury (47).…”
Section: Discussionmentioning
confidence: 99%
“…Ghrelin also improves the histopathological changes in the liver (44). Wild ginseng cambial meristematic cells protect the liver against GalN-induced inflammation, and sesamin ameliorates D-GaIN/lipopolysaccharide-induced hepatic damage (45,46). Forsythiaside has also been reported as a protective compound against lipopolysaccharide (LPS)/D-GalN-induced liver injury (47).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have revealed that LPS may activate Kupffer cells, which can mediate the hepatic inflammatory process by producing TNF-α, IL-1β and IL-6, as well as other proinflammatory cytokines (18,19). TNF-α is an important inflammatory mediators involved in LPS/GalN-induced liver injury, which can potentially induce apoptosis of hepatocytes, subsequently leading to organ failure (20)(21)(22). In addition, TNF-α may initiate the inflammatory cascade and induce the production of other cytokines, including IL-1β and IL-6 (23).…”
Section: A B Discussionmentioning
confidence: 99%
“…This results to multiple organ disfunction syndromes and hepatic encephalopathy [66,67]. In lipopolysaccharide/d-galactosamine (LPS/d-GalN)-induced FHF mice model [68], 100 ppm of sesamin shows improved mortality and promotes serum aminotransferases activity for 6 h. Moreover, sesamin possess hepatoprotection by reducing the regulation of expression of hepatic TNF-α mRNA and protein as well as intercellular adhesion molecule-1 (ICAM-1) and endothelial cell adhesion molecule-1 (ECAM-1). Similarly, sesamin downregulates the expression of TLR4 hindering the MAPK and NF-кB signaling pathway.…”
Section: Liver Diseasementioning
confidence: 99%